The Cancer

Don't Miss

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

Vital Information

Facts

Latest Articles

A Letter to My 2009 Self, Newly Identified With Breast Most cancers

Expensive Brenda,You’ve simply been recognized with inflammatory breast most cancers, and I do know you’re scared to dying. You have got each proper...

FDA Grants Quick Observe Standing to PHST001 for Ovarian Most cancers Therapy

The FDA grants quick observe standing to PHST001 for superior platinum-resistant and platinum-sensitive ovarian most cancers.The U.S. Meals and Drug Administration (FDA) has...

Increasing on a New Option to Handle Polycythemia Vera With out Iron Deficiency

The VERIFY trial explores rusfertide’s position in managing polycythemia vera by controlling pink blood cell manufacturing with out inflicting iron deficiency signs, defined...

I Typically Neglect to Rejoice Survivorship

Mary Sansone is a two-time survivor of acute myeloid leukemia. Atone for all of Mary's blogs right here!5 years have handed since my bone...

You Are Not Alone Whereas Constructing a Assist Crew Throughout Most cancers Care

Each an expert healthcare workforce, in addition to a bunch of private supporters can assist construct a powerful assist community for sufferers who're...

Hot Topics